AT-03 / Attralus - LARVOL DELTA

AT03-001: A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis (clinicaltrials.gov) - P1 | N=13 | Completed | Sponsor: Attralus, Inc. | Active, not recruiting ➔ Completed

Trial completion • Amyloidosis

AT03-001: A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis (clinicaltrials.gov) - P1 | N=13 | Active, not recruiting | Sponsor: Attralus, Inc. | Recruiting ➔ Active, not recruiting | N=20 ➔ 13 | Trial completion date: Aug 2022 ➔ Nov 2022

Enrollment change • Enrollment closed • Trial completion date • Amyloidosis

AT03-001: A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Attralus, Inc. | Enrolling by invitation ➔ Recruiting

Enrollment status • Amyloidosis

AT03-001: A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis (clinicaltrials.gov) - P1; N=20; Enrolling by invitation; Sponsor: Attralus, Inc.

Clinical • New P1 trial • Amyloidosis